Read the March 2021 issue of CFTN
After a prolonged political and social moratorium on the study of psychedelic drugs, we are currently witnessing a renaissance in psychedelic research. Recent work in psychiatry has shown remarkably promising, large-magnitude therapeutic effects, even after single drug administrations.
Since the global novel coronavirus (COVID-19) pandemic began there has been massive disruption to health care services and social support systems. Reports of increased rates of positive urine drug testing results and emergency department visits for nonfatal opioid overdoses provide a glimpse into the increasing toll that the COVID-19 pandemic is having on the prevalence of substance use, the resulting overdose deaths, and health disparities.
The AACC annual meeting went virtual from December 13-17, 2020. During the 5-day conference, a variety of scientific topics covering numerous areas of interest among the in vitro diagnostics community were presented and discussed in both live and on-demand formats. Toxicology and therapeutic drug monitoring as a topic track was extensively represented by 11 scientific sessions and 40 poster presentations.
Contact the editors with any comments or questions.
